Telomir Pharmaceuticals, Inc. Increase (Decrease) in Due to Other Related Parties
Telomir Pharmaceuticals, Inc. (TELO) reported Increase (Decrease) in Due to Other Related Parties of $26.59 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToOtherRelatedParties · last filed 2026-05-14
- Telomir Pharmaceuticals, Inc. increase (decrease) in due to other related parties for the quarter ending 2026-03-31 was $26.59K.
- Telomir Pharmaceuticals, Inc. increase (decrease) in due to other related parties for fiscal 2025 was $224.80K.
| Period end | Increase (Decrease) in Due to Other Related Parties 3 month | Increase (Decrease) in Due to Other Related Parties 12 month |
|---|---|---|
| 2026-03-31 | $26.59K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $224.80K 10-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |